WHO ICTRP trial
Loading, randomized, double-blind, multi-center evaluation of the effectiveness…
ChiCTR2400086796 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400086796 |
|---|---|
| Public title | Loading, randomized, double-blind, multi-center evaluation of the effectiveness and safety of Huangjia Ruangan Granules in the treatment of chronic hepatitis B liver fibrosis (syndrome of liver stagnation and spleen deficiency combined with blood stasis and collateral obstruction) using placebo as a parallel control Phase II clinical trial |
| Scientific title | Huangjia Ruangan Granules Phase II Clinical Trial |
| Primary sponsor | Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Chronic hepatitis B virus liver fibrosis (liver stagnation and spleen deficiency combined with blood stasis and collateral obstruction syndrome) |
| Interventions | High dose:During the 48th week of the treatment period, take basic medication + Huangjia Ruangan granules, 10g/bag, take with warm water in the morning and evening, 1 bag/time, 2 times/day. Basic medication: Entecavir dispersible tablets… |
| Registration date | Jul 11, 2024 |
| Target size | High dose:80;Low dose:80;Placebo control group :80 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: